Contents

Current Molecular Pharmacology, Volume 7 - Number 1

Preface

Preface:

, 7(1): 1

Michael Kahn


DOI: 10.2174/187446720701150105165957




Editorial

Editorial (Thematic Issue: Personalized Cancer Treatment)

, 7(1): 2 - 3

Vassiliki Tzelepi


DOI: 10.2174/187446720701150105170527




Targeted Pathways in Breast Cancer: Molecular and Protein Markers Guiding Therapeutic Decisions

, 7(1): 4 - 21

Helen P. Kourea, Vassiliki Zolota and Chrisoula D. Scopa


DOI: 10.2174/187446720701150105170830




Molecular Testing and Personalized Treatment of Lung Cancer

, 7(1): 22 - 32

Fotis Sampsonas, Daniel Ryan, Dympna McPhillips and David P. Breen


DOI: 10.2174/187446720701150105171219




Current Therapeutic Leads for the Treatment of Melanoma: Targeted Immunotherapy in the Post-genomic Era

, 7(1): 33 - 43

Anastasios D. Papanastasiou, Chaido Sirinian, Haralabos P. Kalofonos and Maria Repanti


DOI: 10.2174/187446720701150105171803




Anti-cancer Drug Discovery: Update and Comparisons in Yeast, Drosophila, and Zebrafish

, 7(1): 44 - 51

Guangxun Gao, Liang Chen and Chuanshu Huang


DOI: 10.2174/1874467207666140702113629




Theories and Treatment of Drug Dependency: A Neurochemical Perspective

, 7(1): 52 - 66

Sheila Pakdaman, Richard E. Wilcox and Joseph D. Miller


DOI: 10.2174/1874467207666141017150625




Involvement of β-arrestin-2 and Clathrin in Agonist-Mediated Internalization of the Human Cannabinoid CB2 Receptor

, 7(1): 67 - 80

Xiaopan Chen, Congxia Zheng, Jing Qian, Steven W. Sutton, Zhen Wang, Jianxin Lv, Changlu Liu and Naiming Zhou


DOI: 10.2174/1874467207666140714115824




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science